Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
JAMA Otolaryngology-- Head & Neck Surgery
|
February 26, 2026
Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial
Glenn J Hanna, Olga Y Zamulko, Punita Grover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2022
Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
Jennifer L Leddon, Shuchi Gulati, Sulsal Haque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2025
Milademetan in advanced solid tumors with MDM2 amplification and wild-type TP53: pre-clinical and phase 2 clinical trial results
Ecaterina E Dumbrava, Thomas E Stinchcombe, Mrinal Gounder, et al.
Journal of the National Cancer Institute
|
December 4, 2025
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience
Luana G Sousa, James Edward Bates, Payal Anand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2022
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Trisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, et al.
NPJ Precision Oncology
|
July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers
Emily L Hoskins, Raven Vella, Julie W Reeser, et al.
Journal for Immunotherapy of Cancer
|
July 25, 2025
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors
Mohammed M Milhem, Trisha M Wise-Draper, Sunandana Chandra, et al.
JAMA Network Open
|
March 28, 2022
Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer
Julie Fu, Sonya A Reid, Benjamin French, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 8, 2025
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE)
Michael K Wong, Mohammed M Milhem, Joseph J Sacco, et al.
Nature Communications
|
April 8, 2023
Single cell transcriptomic analysis of HPV16-infected epithelium identifies a keratinocyte subpopulation implicated in cancer
Mary C Bedard, Tafadzwa Chihanga, Adrean Carlile, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
JAMA Otolaryngology-- Head & Neck Surgery
|
February 26, 2026
Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial
Glenn J Hanna, Olga Y Zamulko, Punita Grover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2022
Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
Jennifer L Leddon, Shuchi Gulati, Sulsal Haque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2025
Milademetan in advanced solid tumors with MDM2 amplification and wild-type TP53: pre-clinical and phase 2 clinical trial results
Ecaterina E Dumbrava, Thomas E Stinchcombe, Mrinal Gounder, et al.
Journal of the National Cancer Institute
|
December 4, 2025
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience
Luana G Sousa, James Edward Bates, Payal Anand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2022
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Trisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, et al.
NPJ Precision Oncology
|
July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers
Emily L Hoskins, Raven Vella, Julie W Reeser, et al.
Journal for Immunotherapy of Cancer
|
July 25, 2025
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors
Mohammed M Milhem, Trisha M Wise-Draper, Sunandana Chandra, et al.
JAMA Network Open
|
March 28, 2022
Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer
Julie Fu, Sonya A Reid, Benjamin French, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 8, 2025
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE)
Michael K Wong, Mohammed M Milhem, Joseph J Sacco, et al.
Nature Communications
|
April 8, 2023
Single cell transcriptomic analysis of HPV16-infected epithelium identifies a keratinocyte subpopulation implicated in cancer
Mary C Bedard, Tafadzwa Chihanga, Adrean Carlile, et al.
Page
of 8